All Updates

All Updates

icon
Filter
Funding
3D BioFibR raises CAD 3.52 million in seed funding
Bio-based Materials
Jul 20, 2023
This week:
Funding
Matr Foods raises EUR 20 million in debt funding to build mycelium meat factory
Plant-based Meat
Today
Last week:
M&A
Platform Science to acquire Trimble's global transportation telematics business units
Truck Industry Tech
Yesterday
Funding
Whatfix raises USD 100 million in Series E funding to expand business
EdTech: Corporate Learning
Yesterday
Product updates
Sky Mavis launches cross-game onboarding solution
Web3 Ecosystem
Sep 14, 2024
Funding
Bicara Therapeutics raises USD 315 million in IPO; plans to develop lead candidate ficerafusp alfa
Precision Medicine
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Precision Medicine
Sep 13, 2024
Partnerships
Moffitt Cancer Center partners with AstraZeneca to advance oncology cell therapies
Cell & Gene Therapy
Sep 13, 2024
Product updates
Quandela launches European quantum computer in North America
Quantum Computing
Sep 13, 2024
Partnerships
IonQ achieves high qubit gate fidelity on barium development platform
Quantum Computing
Sep 13, 2024
Partnerships
Massive Bio and Foundation Medicine partner to improve cancer clinical trial enrollment
Clinical Trial Technology
Sep 13, 2024
Bio-based Materials

Bio-based Materials

Jul 20, 2023

3D BioFibR raises CAD 3.52 million in seed funding

Funding

  • Canadian biomaterials company producing protein fibers, 3D BioFibR, has raised over CAD 3.52 million (~USD 2.7 million) in seed funding led by Invest Nova Scotia. Build Ventures, Concrete Ventures, and Globalive Capital also participated in the funding round.

  • The funding will be used to bring the company’s collagen fiber products to market and expand 3D BioFibR's facilities to include a climate-controlled biomanufacturing clean room.

  • Founded in 2020, 3D BioFibR produces high-value collagen fibers for tissue engineering and medical applications using its proprietary dry-spinning process, which produces fibers that closely resemble natural collagen fibers. The company has also focused beyond collagens, reporting to have spun various other biopolymers, including spider silk, fibrin, and chitosan.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.